The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure

Lignende værker

• The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
  af: Jabbour, Elias, et al.
  Udgivet: (2011)
• The Clinical Significance of Achieving Different Levels of Cytogenetic Response in Patients with Chronic Phase Chronic Myeloid Leukemia After Failure to Frontline Therapy: Is Complete Cytogenetic Response the Only Desirable Endpoint?
  af: Cortes, Jorge, et al.
  Udgivet: (2011)
• EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience
  af: Jabbour, Elias, et al.
  Udgivet: (2012)
• Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy
  af: Quintás-Cardama, Alfonso, et al.
  Udgivet: (2009)
• Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia
  af: Quintás-Cardama, Alfonso, et al.
  Udgivet: (2009)